In November 2022 the Brazilian Agência Nacional de Vigilância Sanitária – ANVISA approved SocraTec R&D and SocraMetrics to conduct clinical trials and Data Management & Biostatistics for clinical trials, fully meeting the agency’s stringent regulations. With this certificate we will be able to help our customers achieving their goals on the Brazilian market.
We are really proud of our team and the effort everyone put into the application and inspection processes.